DOI: 10.1159/hrp/adaag020.330 ISSN: 1663-2818

P-272: Evaluation of a structured transition program for adolescents with type 1 diabetes in Salta

E Bettancourth, M G d L Pacheco, N Helena, L Loutayf, D Martinez Taboada, M Diaz heredia, F Soto, M Burgos

Abstract

Introduction

The transition from pediatric to adult healthcare is a critical period for adolescents with Type 1 Diabetes (T1D), often associated with clinical and psychosocial challenges

Objectives

This study aimed to compare metabolic control, quality of life, and hospitalization rates before and after participation in a structured transition program.

Methods

A longitudinal, pre-post intervention cohort study was conducted at Dr. Arturo Oñativia and Público Materno Infantil hospitals in Salta, Argentina (January 2022 to June 2024). Participants included 13 adolescents with T1D (aged 14-18) who completed the program. Data analysis included clinical characteristics, HbA1c, glucose variability, hospitalization rates, and validated surveys: PEDsQL 3.0 (Diabetes Module) and TRAQ 5.0.

Results

No statistically significant changes were observed in metabolic parameters, including HbA1c, hypoglycemia/hyperglycemia frequency, or lipid profile. However, significant improvements were found in overall perceived quality of life (PEDsQL Total, p=0.0007), specifically in the communication domain (p=0.0205). Preparation for transition (TRAQ 5.0) also showed significant improvements in medication management (p=0.0425), appointment follow-up (p=0.0098), communication (p=0.0020), and daily activities (p=0.0176). A reduction in the absolute number of hospitalizations was noted, though not statistically significant (p=0.2266).

Conclusions

While the program did not yield immediate metabolic improvements, it significantly enhanced psychosocial and educational factors essential for self-management and a successful transition to adult care. These findings suggest that structured programs strengthen adolescent autonomy in navigating the health system.

More from our Archive